⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperidine SCHEMBL3005686 | 0.97 | — | — | |
| Piperidine SCHEMBL27896621 | 0.97 | ALDH1A1 (0.60) | — | |
| Piperidine SCHEMBL9800122 | 0.97 | ALDH1A1 (0.60) | — | |
| Piperidine SCHEMBL11775250 | 0.97 | ALDH1A1 (0.60) | — | |
| Pyrrolidine SCHEMBL15602911 | 0.85 | — | — | |
| Piperazine SCHEMBL27879283 | 0.85 | HIF1A (0.50) | — | |
| Piperazine SCHEMBL791431 | 0.85 | — | — | |
| Piperidine SCHEMBL7523716 | 0.84 | ALDH1A1 (0.53) | — | |
| Piperidine SCHEMBL28074884 | 0.84 | ALDH1A1 (0.45) | — | |
| Pyrrolidine SCHEMBL631271 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200030787-A1 | Ion-Conducting Membranes | DIOXIDE MATERIALS, INC | 2020-01-30 | — | — | US | claimed |
| US-20250066521-A1 | Ion-Conducting Membranes | GREENLYZER MATERIALS PTE. LTD. (SG) | 2025-02-27 | — | — | US | disclosed |
| US-20250066934-A1 | Methods of Operating a Water Electrolyzer | U.S. DEPARTMENT OF ENERGY | 2025-02-27 | — | — | US | disclosed |
| US-20200030787-A1 | Ion-Conducting Membranes | DIOXIDE MATERIALS, INC | 2020-01-30 | — | — | US | disclosed |
| WO-2015042405-A1 | PH SWITCHABLE REAGENTS AND METHODS FOR THEIR USE | IMPOSSIBLE FOODS INC. (US) | 2015-03-26 | — | — | WO | disclosed |
| US-8030487-B2 | 2-amino—5-substituted pyrimidine inhibitors | TARGEGEN, INC. (US) | 2011-10-04 | — | — | US | disclosed |
| US-8022222-B2 | Glucokinase activators | ARRAY BIOPHARMA, INC. (US) | 2011-09-20 | — | — | US | disclosed |
| US-20090247526-A1 | GLUCOKINASE ACTIVATORS | ARRAY BIOPHARMA INC. (US) | 2009-10-01 | — | — | US | disclosed |
| US-20080027070-A1 | 2-AMINO--5-SUBSTITUTED PYRIMIDINE INHIBITORS | TARGEGEN, INC. (US) | 2008-01-31 | — | — | US | disclosed |
| WO-2008008234-A1 | 2-AMINO-5-SUBSTITUTED PYRIMIDINE INHIBITORS | TARGEGEN, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-1863794-A2 | PYRIMIDINE COMPOUNDS AND METHODS OF USE | Targegen, Inc. (US) | 2007-12-12 | — | — | EP | disclosed |
| US-20060247250-A1 | Pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2006-11-02 | — | — | US | disclosed |
| WO-2006101977-A2 | PYRIMIDINE COMPOUNDS AND METHODS OF USE | TARGEGEN, INC. (US) | 2006-09-28 | — | — | WO | disclosed |